As we all know, since the outbreak of the new crown , the Chinese government has been working hard to maintain the safety of its people. Not only is the 1.4 billion people vaccinated for free, but the country also covers the cost of treatment for patients with COVID-19. Against this background, many people are beginning to worry, will the country lose too much? But in fact, my country's vaccines not only did not lose money, they also made money. Take Kexing as an example, this pharmaceutical company made a net profit of 50 billion yuan in the first half of the year. So, how much money does the new crown vaccine really attract?
Covid-19 vaccine
The Covid-19 epidemic itself is a battlefield without gunpowder and smoke. Although China has achieved excellent results in this epidemic prevention and control, and the national epidemic situation has stabilized, it cannot relax its vigilance for the time being.
Compared with the panic in the early stage of the epidemic, people across the country are now actively engaged in work and life, and all vaccination work across the country is proceeding in an orderly manner. The country actively responds to the call not to give up anyone, and is very rigorous in tasks such as vaccine development and vaccination. What is gratifying is that the cost of China vaccine and new crown virus treatment is borne by the state, and people can rest assured that their health will be handed over to the motherland to protect them.
Kexing vaccine is now actively used throughout China and globally. At the same time, Kexing vaccine has successfully opened its doors to the world, and more and more countries have voluntarily vaccinated China Kexing vaccine. . Under the violent attack of the new coronavirus, the global demand for vaccines has gradually increased. According to statistics, nearly 40% of the global population has completed the first dose of the new crown vaccine.
How much money does the new crown vaccine attract?
During the severe epidemic,The new crown vaccine is nothing more than a centering agent against the virus. The research and development of the new crown vaccine coupled with its significant defensive effect has gradually become the "sweet pastry" of China and some countries in the world. More and more countries are favoring the use of Chinese vaccines. Since then, the performance of China Kexing Vaccine has made a qualitative leap. And the performance of the vaccine manufacturer has continued to improve. So how much money does the vaccine really attract?
According to statistics, China Biopharmaceuticals 's parent company has a profit of 8.48 billion yuan, a subsidiary's profit of 7.585 billion yuan, and a 15.03% equity interest in Kexing. According to data, the profit of Kexing Vaccine in the first half of this year is close to 50 billion yuan. Since the outbreak of the epidemic, it has not been difficult for China to rush for vaccines. More and more countries have been vaccinated with Kexing vaccine, which has achieved a significant effect of suppressing the virus infection. In addition, Kexing vaccine has obtained emergency use rights in 50 countries around the world and has entered the WHO emergency use list.
Nowadays, such as Kexing Vaccine, it is known as the best-selling vaccine product during the epidemic, and many manufacturers have achieved excellent results. It is reported that China Kexing's profit in the first half of the year reached 50 billion yuan. More than 1 billion doses of vaccines have been vaccinated globally, and nearly 900 million doses of vaccine cooperation agreements have been signed with nearly 20 countries in the international community in the first half of this year.
global vaccine sales
According to research statistics, my country has developed a total of five vaccines and all have been approved for use. The five models are divided into three categories according to technology, namely inactivated vaccine , adenovirus vector vaccine, and recombinant protein vaccine . The new crown vaccine has continued to sell well since the outbreak. In addition, the amount of vaccine sales in other countries is also very considerable. For example, Cansino Biotech Co., Ltd. .
Cansino Biological Co., Ltd. achieved a profit of more than 2 billion yuan in the first half of the year, and a net profit of more than 900 million yuan.
With the continuous increase of international production capacity, the international overseas market is continuously expanded and opened, and other vaccine industries in China can continue to achieve the flexibility of contributing performance. According to data from the National Health Commission, my country has 7 vaccines that have passed the emergency use right and have successfully applied for marketing. Another 21 vaccines are entering clinical trials. Although all kinds of vaccines are coming one after another, the international epidemic has not yet been alleviated, and the demand for vaccines in countries around the world is still very large.
China's vaccines help the world
China said that China will continue to step up vaccine assistance, and will actively and continuously extend a helping hand to developing countries to help them recover as quickly as possible and stabilize the epidemic . China's epidemic prevention work will also continue, and China will continue to provide Chinese vaccines, and China has donated a total of US$100 million to the implementation plan of the new crown vaccine. In other words, Chinese vaccines will sweat this battlefield without gunpowder and smoke, and contribute to the global fight against the epidemic.
The Chinese side stated that the current global epidemic situation has not yet been stabilized and cannot be slackened. Countries should step up various epidemic prevention measures, actively launch various vaccination tasks, and greatly suppress virus mutations. spread. The imbalance in the distribution of vaccines in the international community is still serious, so the international community’s assistance is needed to build confidence for countries in difficulty. China will actively take a series of measures to promote the rational distribution of vaccines in the international community and achieve epidemic prevention in the vast number of developing countries.
